IngentaConnect Trabecular bone microarchitecture after alendronate treatment of ...

Abstract:

Objective: To compare the microarchitecture of iliac crest trabecular bone from women treated for two to three years with alendronate versus that of women treated with placebo.

Research design and methods: Three-dimensional microcomputed tomography (micro-CT; resolution 20μm) and two-dimensional histomorphometry (resolution 5–7μm) were used to examine trabecular bone from single transilial biopsies obtained at the completion of clinical trials.

Main outcome measures: Microarchitectural variables, including bone volume, trabecular number, trabecular thickness, and trabecular spacing in specimens from alendronate- and placebo-treated women were examined. Three-dimensional images of trabecular bone from both groups were constructed from CT images. Correlations among variables and between techniques were also calculated.

Results: Eighty-eight specimens were suitable for evaluation by both techniques. As measured by two-dimensional histomorphometry, bone volume fraction (as a proportion of total volume) and trabecular thickness were significantly greater in alendronate specimens, 17.1 ± 5.5% vs. 13.4 ± 5.5% (p = 0.0043) and 127 ± 29 μm vs. 109 ± 28μm (p = 0.0090), respectively, and trabecular spacing was significantly smaller, 729 ± 227μm vs. 862 ± 338μm (p = 0.005). Micro-CT yielded similar findings: bone volume and trabecular number were significantly greater in alendronate specimens: 19.4 ± 6.2% vs. 16.2 ± 6.3% (p = 0.0412) and 1.46^± 0.32 vs. 1.31^± 0.33 per mm (p = 0.0346). Two-dimensional and micro-CT measured characteristics correlated strongly with one another, with Pearson product moment correlation coefficients ranging from 0.60 (for trabecular thickness) to 0.83 (for bone volume).

Conclusions: Trabecular microarchitecture of the ilium, whether studied by two- or three-dimensional methods, is better (greater bone volume, greater trabecular thickness, decreased trabecular spacing) after alendronate treatment than after two to three years of treatment with placebo. Bone volume in a trabecular region is strongly correlated to its microarchitecture, suggesting that bone quantity predicts values for these microarchitectural endpoints.

Keywords: ALENDRONATE; HISTOMORPHOMETRY; MICRO-COMPUTED TOMOGRAPHY; MICROARCHITECTURE; OSTEOPOROSIS

Document Type: Research article

DOI: 10.1185/030079904X20259

Affiliations: 1: Osteoporosis Research Center, Creighton University, Omaha, NE, USA 2: Merck Research Laboratories, Rahway, NJ, USA 3: Faculté de Médecine R. Laënnec, INSERM Unité 403, Lyon, France 4: Formerly of Merck Research Laboratories (now retired)

Your trusted access to this article has expired.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax Refund Policy

Trabecular bone microarchitecture after alendronate treatment of osteoporotic women